LICORbio Expands Portfolio with SERVA Electrophoresis Acquisition
LICORbio, an innovator in life science imaging and analytical solutions, has made a strategic acquisition of SERVA Electrophoresis, enhancing its position in protein analysis. This acquisition broadens the range of electrophoresis solutions LICORbio offers, presenting a comprehensive suite of tools tailored to proteomics researchers.
Benefits of the Acquisition
This acquisition marks a significant step for LICORbio, enabling the company to deliver an integrated workflow from sample preparation to analysis. By combining SERVA's proprietary technologies with LICORbio's renowned imaging platforms, customers will benefit from a seamless workflow experience, increasing the accuracy and efficiency of their protein, DNA, and RNA analysis.
Leadership Insights
LICORbio's CEO, Tom Reslewic, emphasized that the acquisition aligns with the company's strategic focus on technological expansion, highlighting the importance of staying attuned to the research community's needs. The integration aims to provide tools that enhance reproducibility and efficiency in laboratory workflows.
A Collaborative Future
Bambi Reynolds, senior vice president at LICORbio, expresses enthusiasm about the SERVA team's integration, viewing it as more than just an expansion of products, but a chance to innovate together and support the broader scientific community. This collaboration is grounded in a vision of unifying efforts towards better customer outcomes.
About SERVA Electrophoresis
Founded in 1953, SERVA boasts a legacy of innovation in gel electrophoresis with a portfolio of reagents and consumables known for their performance across various applications. The alignment of SERVA's technology with LICORbio's goals reinforces their shared mission of empowering discoveries through high-quality tools.
Commitment to Uninterrupted Service
The acquisition process commenced immediately, focusing on ensuring that customers continue to access SERVA's product line without disruption. LICORbio plans to maintain SERVA's existing facilities, providing ongoing support while incorporating its global infrastructure to enhance service quality.
About LICORbio
LICORbio is a leader in developing imaging systems and analytical tools that enable scientists to extract vital insights across proteomics, genomics, and cell biology. The company emphasizes the importance of delivering reliable solutions that accelerate discovery and ensure reproducibility in research environments.
Frequently Asked Questions
1. Why did LICORbio acquire SERVA Electrophoresis?
The acquisition is aimed at expanding LICORbio's electrophoresis product offerings and enhancing integration capabilities for proteomics researchers.
2. How will this acquisition benefit customers?
Customers will enjoy an improved workflow experience that combines SERVA’s technologies with LICORbio’s imaging solutions for accurate and efficient analysis.
3. What is SERVA known for?
SERVA has built a strong reputation in gel electrophoresis, offering high-quality reagents and consumables for diverse applications since 1953.
4. Will there be changes to SERVA’s product line?
Customers can expect uninterrupted access to SERVA's products, with enhanced service and support following the acquisition.
5. What is LICORbio's mission?
LICORbio is dedicated to empowering scientific discovery by providing accessible and high-quality tools for the life sciences community.
